Published:Wednesday | November 12, 2014 | 12:00 AM
Charles Mattocks celebrates World Diabetes Day 2014 in JamaicaFor World Diabetes Day 2014, International Diabetes Federation's (IDF) Blue Circle Champion and celebrity chef, Charles Mattocks, will be heading to Jamaica to launch an extensive campaign in...
STANFORD, California (AP): Top medical experts studying the spread of Ebola say Americans should expect more cases to emerge in the United States by year's end as infected people arrive here from West Africa, including American doctors and nurses returning from the hot zone and people fleeing from the deadly disease.
The Pan American Health Organization and World Health Organization (PAHO-WHO) are mobilising teams of experts in outbreak alert and response to help member states in Latin America and the Caribbean ensure they are prepared for any potential introduction of the Ebola virus disease (EVD).
Weight-loss surgery to prevent Type Two diabetes? New research published in this week's Lancet Diabetes & Endocrinology suggests that bariatric surgery - often thought of as a drastic, last-resort measure for weight loss - could cut the risk of developing Type Two diabetes by 80 per cent in those who are obese.
In October, Prime Minister Portia Simpson Miller activated the multi-agency Ebola Contingency Action Plan, under the National Health Emergency Plan, with a budget of $500 million..
As part of the heightened preparedness by the Jamaican Government to address possible cases of Ebola in the island, an isolation unit has been identified and outfitted at the country's National Chest Hospital in St Andrew.
With an artillery of pain-relieving modalities, including heat ultrasound electrotherapy devices and magnetic field therapy, it's no wonder that at Physical Therapy Solutions we are seeing more patients recovering from the chikungunya virus.
Colorado State University (CSU) in the United States (US) has been awarded US$2 million by the US Department of Defense to begin developing and manufacturing an Ebola vaccine, officials said on Monday.
A team of researchers from Harvard and Boston universities in the United States has invented a remarkably well-developed new screening technology that could allow quick, cheap, portable, and accurate testing for Ebola - and most other diseases, too.
An experimental chikungunya vaccine prompted an immune response in all 25 volunteers in an early-stage clinical trial. Researchers believe an effective vaccine could prevent future outbreaks of the disease.
